Carly Kenselaar

Stock Analyst at Citigroup

(3.02)

# 1,364

Out of 4,944 analysts

8

Total ratings

83.33%

Success rate

47.59%

Average return

Main Sectors:

Top Industries:

Stocks Rated by Carly Kenselaar

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	KRYS Krystal Biotech	Maintains: Neutral	$155 → $176	$149.36	+17.84%	2	Jul 10, 2025
	TVTX Travere Therapeutics	Maintains: Buy	$35 → $32	$18.05	+77.29%	6	Jun 11, 2025

Krystal Biotech

Jul 10, 2025

Maintains: Neutral

Price Target: $155 → $176

Current: $149.36

Upside: +17.84%

Travere Therapeutics

Jun 11, 2025

Maintains: Buy

Price Target: $35 → $32

Current: $18.05

Upside: +77.29%